• Systems
  • Applications
  • News & Events
  • About
  • Contact
    • Distributor Login
Celsee
  • Systems
  • Applications
  • News & Events
  • About
  • Contact
    • Distributor Login

News

Celsee and Kindstar Global Collaborate to Bring Advanced Tools for Monitoring Circulating Tumor Cells to Scientists in China

Ann Arbor, Mich., and Beijing, China — January 14, 2020 — Celsee, Inc., a leading provider of single-cell isolation technology, and Kindstar Global, the largest medical esoteric testing service group in China, today announced a purchase agreement to provide scientists at the Kindstar Laboratory System in China with Celsee’s Genesis System for monitoring circulating tumor cells (CTCs) in lung, breast, and bladder cancers as well as single-cell research. In addition, Kindstar will become a distributor of Celsee’s products in China.

For this cancer research, Kindstar scientists will use the BioINK kit, which was developed by IncellDx for CTC enumeration in therapeutic monitoring and is performed on Celsee’s Genesis System utilizing the Celselect™ Technology. Now, researchers will gain access to Celsee’s Genesis System, which has better capture efficiency and detection of CTCs compared to other CTC enumeration platforms.

See how the Genesis System can help you get the most out of CTCs with better detection and monitoring. Download our CTC Application Note »

“Kindstar Global is leading the way for oncology research and testing in China, and we are committed to implementing the most advanced tools for that work,” said Dr. Shiang Huang, Founder and CEO of Kindstar. “We are truly impressed by the capabilities of Celsee’s single-cell isolation and enumeration technology and are eager to use it in our own laboratories as well as to make it available to scientists throughout China.”

John Stark, Chief Executive Officer of Celsee, commented: “We are very excited to announce the partnership with Kindstar and the opportunity to bring Celsee technology to the clinical research market in China. Our team has worked closely with IncellDx to develop workflows that combine our single-cell tools with their flow cytometry classification assays and BioINK assays for CTC enumeration to assess disease progression and response to therapy.”

Celsee’s technology enables high-throughput analysis of single cells with industry-leading capture rates. The Genesis System supports two slide technologies. Celselect slides enrich and enumerate CTCs with high capture efficiency and detection rates. Celsingle™ slides use a gentle, gravity-based method to capture and isolate thousands of individual cells while maintaining viability and structural integrity for robust downstream analysis in both genomic and proteomic applications and improved sensitivity compared to other single-cell technologies.

About Kindstar Group

Kindstar Global Technology is the first and biggest leading-edge medical esoteric testing service group in China. It provides 3000+ tests in hematology, oncology, medical genetics, cardiovascular diseases, infectious diseases and autoimmune diseases to medical specialties including internal medicine department, surgery department, gynecology department and pediatrics department in more than 3000 hospitals. Kindstar also provides medical research, clinical trial services and translational medicine study services to physicians, medical science and technology institutions and pharmaceutical companies. Kindstar Global has been committed to leading China’s esoteric testing technology and services and improving China’s specialty diagnosis and individualized health. For more information, visit en.kindstarglobal.com

About Celsee, Inc.

Celsee, Inc., a privately held company in Ann Arbor, Michigan, is breaking through the traditional barriers of single-cell analysis and delivering clinical-grade technology designed to support the life sciences revolution and precision medicine. Based on a gentle, gravity-induced, micro-well isolation technique, the patented technology forms the foundation for an elegant, scalable, and flexible single-cell analysis platform that makes more experiments feasible. Celsee’s first product, the Genesis System, enables scientists to analyze and interpret cellular behavior and collect previously inaccessible information for improved results in applications such as proteogenomics, next-generation sequencing, immune monitoring, and cell therapy. For more information, visit www.celsee.com.

Media Contacts

For Kindstar:
Shiang Huang, CEO
shianghuang@kindstar.com.cn

For Celsee:
Colin Sanford
Bioscribe, Inc.
203.918.4347
colin@bioscribe.com

 

[wp_social_sharing social_options=’facebook,twitter,linkedin,’ twitter_username=’celsee_inc’ show_icons=’0′ before_button_text=” text_position=” social_image=”]

CONTACT A SPECIALIST

  • Systems
  • Applications
  • Support
  • News & Events
  • About Us
  • Careers
  • Contact Us
  • Distributors

© 2021 Celsee, Inc. – All Rights Reserved Privacy Policy – Terms of Use 100 Phoenix Drive – Suite 321 Ann Arbor, MI 48108

Contact us today 866.748.1448 248.319.6919


LinkedInTwitterInstagram

We use cookies in order to improve and customize your browsing experience. By continuing, you are consenting to our privacy policy. Accept Decline Read our Privacy Policy
Necessary
Always Enabled

This is an necessary category.

Non Necessary

This is an non-necessary category.

Save & Accept
Speak To An Expert About Your Single-Cell Questions

If you would like to have a Celsee representative contact you about pricing, products, and other details regarding the Genesis System or its applications, please fill out the form below:

Terms of Use | Privacy Policy

Contact Tech Support


 

Technical Support


Contact Sales


Terms of Use | Privacy Policy

Contact Us


Terms of Use | Privacy Policy

Let’s Talk


Fill out this form to have a Celsee representative contact you about pricing, products, and other details regarding the Genesis System.

Terms of Use | Privacy Policy

Get the Latest Updates on Life Sciences Technology Delivered To Your Inbox

Terms of Use | Privacy Policy

Technical Support


Contact Us


 

Terms of Use | Privacy Policy

Be Connected to a Distributor

Submit an Application

Submit an Application

For consideration, please fill the form out below. No phone calls, please. Only qualified candidates will be contacted.

[contact-form-7 id=”1065″ title=”Job Application Form”]

*Celsee, Inc. is an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status or any other characteristic protected by law.